查看购物车
  • Traditional Chinese
  • English
  • Japanese
全球孕产妇保健市场 2023-2030
市场调查报告书
商品编码
1350998

全球孕产妇保健市场 2023-2030

Global Maternal Health Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

预计在预测期内（2023-2030 年），全球孕产妇保健市场将以 9.0% 的复合年增长率成长。市场的成长归因于对采用基于证据的最佳实践的需求不断增长，这些最佳实践可以带来更好的孕产妇和婴儿健康结果。如今，在患者护理品质、安全性以及孕妇和产后患者的可及性方面采用最高标准的医院已获得认证，以向消费者介绍这些机构。因此，市场参与者正在推出新产品来满足新节目的需求。例如，2022 年，医疗保险和医疗补助服务中心 (CMS) 在其孕产妇和婴儿健康计划中启动了一项新计划，旨在减少低风险剖腹产，以增强婴儿和孕产妇健康。该计划的核心是学习合作，为医疗补助和 CHIP 机构提供防止低风险剖腹产的策略，并直接与各州合作，在其州采用经过研究证明的最佳实践。

细分市场前景

全球孕产妇保健市场按类型、併发症和护理进行细分。依类型，市场分为子宫内、异位、输卵管等。依併发症，市场细分为流产、早产、子癎前症、妊娠糖尿病、前置胎盘等。此外，根据护理，市场分为产前护理和产后护理。在併发症中，由于全球流产增加导致对孕产妇保健的需求不断增长，预计流产细分市场将占据相当大的市场份额。例如，根据美国国立卫生研究院（NIH）的数据，到2022年，20岁至30岁、妊娠不足20週的女性流产的机率为8.9%。对于40岁以上的女性，这一比例上升至74.7%。既往产科史是早期流产风险的重要预测因子。一次流产、两次连续流产或三次或以上连续流产后，下次妊娠流产的几率分别约为 20%、28% 和 43%。

预计妊娠糖尿病细分市场将在全球孕产妇保健市场中占据相当大的份额

在併发症中，妊娠糖尿病细分市场预计将在全球孕产妇保健市场中占据相当大的份额。这一细分市场的成长归因于该地区人口中妊娠糖尿病盛行率的不断上升。妊娠糖尿病可以透过饮食、运动来控制，在某些情况下还可以根据严重程度进行胰岛素治疗。一种称为糖尿病的慢性（长期）疾病会影响身体将食物转化为能量的方式。妊娠糖尿病治疗的目标是维持与未患有此疾病的孕妇相当的血糖值。特殊饮食方案、规律运动计画、每日血糖测试和胰岛素注射都是治疗的一部分。根据美国疾病管制与预防中心的数据，如果女性没有患有糖尿病，她在怀孕期间可能会患上妊娠糖尿病。在美国，妊娠糖尿病每年影响 2% 至 10% 的怀孕。维持妊娠糖尿病的控制可确保安全怀孕和健康分娩。

区域展望

全球孕产妇保健市场根据地理位置进一步细分，包括北美（美国和加拿大）、欧洲（英国、义大利、西班牙、德国、法国和欧洲其他地区）、亚太地区（印度、中国、日本、韩国和亚洲其他地区）以及世界其他地区（中东和非洲以及拉丁美洲）。其中，由于公众健康意识的增强和对创新医疗技术需求的增加，预计亚太地区将在全球市场中占据显着份额。

北美地区预计全球孕产妇保健市场复合年增长率显着成长

在所有地区中，预计北美在预测期内将以相当大的复合年增长率成长。区域成长归因于该地区对计划生育的需求不断增长。有机会利用避孕和计划生育服务的妇女可以间隔怀孕并降低困难的风险。因此，市场参与者正在推出新产品来满足孕产妇死亡率的需求。据美国疾病管制与预防中心称，这份报告更新了先前的一份报告，该报告显示了2018 年至2020 年的孕产妇死亡率。在美国，2021 年有1,205 名妇女因怀孕相关原因死亡，而2021 年为861 名。2020 年和2019 年分别为754 例。与2020 年每10 万名活产 23.8 例死亡和2019 年每10 万名活产 20.1 例死亡相比，2021 年孕产妇死亡率为32.999例。 2021 年，非西班牙裔黑人（即黑人）女性的孕产妇死亡率为每 10 万活产 69.9 人，是非西班牙裔白人（即白人）女性死亡率（26.6 人）的 2.6 倍。黑人女性的发生率明显高于白人和西班牙裔女性。 2020 年至 2021 年间，西班牙裔和所有其他种族群体的人数显着增加。

2018年，孕产妇死亡率为每10万活产儿17.4人死亡，2019年为每10万活产儿20.1人死亡，2020年为每10万活产儿23.8人死亡，2021年为每10万活产人32.9人死亡。

目录

第 1 章：报告摘要

  • 目前行业分析及成长潜力展望
  • 研究方法和工具
  • 市场区隔
    • 按细分
    • 按地区

第 2 章：市场概述与见解

  • 报告范围
  • 分析师见解和当前市场趋势
    • 主要发现
    • 建议
    • 结论

第 3 章：竞争格局

  • 主要公司分析
  • Agile Therapeutics, Inc.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Boston MedTech Advisors, Inc.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • MCH Ventures, Inc.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • 关键策略分析

第 4 章：市场细分

  • 按类型分類的全球孕产妇保健市场
    • 宫内
    • 异位
    • 输卵管
    • 其他（腹腔内妊娠、单胞胎妊娠、多胞胎妊娠）
  • 全球孕产妇保健市场的复杂情况
    • 流产
    • 早产和分娩
    • 子痫前症
    • 妊娠糖尿病
    • 前置胎盘
    • 其他（严重出血和感染）
  • 按护理分類的全球孕产妇保健市场
    • 产前护理
    • 产后护理

第 5 章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第 6 章：公司简介

  • Apollo Hospitals Enterprise Ltd.
  • Ann & Robert H. Lurie Children's Hospital of Chicago
  • Cincinnati Children's Hospital Medical Center
  • Fuji Latex Co., Ltd.
  • Jiovio Healthcare
  • Johnson & Johnson Services, Inc.
  • March of Dimes
  • McKinsey & Co.
  • MedTech Boston
  • Merck & Co., Inc.
  • Okamoto Industries Co., Ltd.
  • RAND Corp.
  • Reckitt Benckiser Group
  • Sanofi
Product Code: OMR2027591

Title: Global Maternal Health Market Size, Share & Trends Analysis Report by Type (Intrauterine, Ectopic, Tubal, and Others), by Complication (Miscarriage, Premature Labor & Birth, Preeclampsia, Gestational Diabetes, Placenta Previa, and Others), and by care (Prenatal Care, and Postnatal Care),Forecast Period (2023-2030).

The global Maternal Health market is anticipated to grow at a CAGR of 9.0% during the forecast period (2023-2030). The growth of the market is attributed to the growing demand for adopting evidence-based best practices that can lead to better maternal and infant health outcomes. Nowadays, hospitals that have adopted the highest standards in terms of patient care quality, safety, and accessibility for pregnant and postpartum patients have been awarded a certification that informs consumers about the establishments. Accordingly, market players are coming up with new products to cater to the demand for new programs. For instance, in 2022, the Centers for Medicare & Medicaid Services (CMS) launched a new programme within its maternity and baby health programme aimed at reducing low-risk caesarean deliveries in order to enhance both infant and maternal health. The core of this programme is a learning collaborative that provides Medicaid and CHIP agencies with strategies to prevent low-risk caesarean deliveries and works directly with states to adopt research-proven best practices in their state.

Segmental Outlook

The global maternal health market is segmented by type, complication, and care. Based on type, the market is sub-segmented into intrauterine, ectopic, tubal, and others. Based on the complications, the market is sub-segmented into miscarriage, premature labor and birth, preeclampsia, gestational diabetes, placenta previa, and others. Further, on the basis of care, the market is sub-segmented into prenatal care and postnatal care. Among the complications, the miscarriage sub-segment is anticipated to hold a considerable share of the market owing to the growing demand for maternal health care as a result of an increase in miscarriages across the globe. For instance, in 2022, according to the National Institute of Health (NIH), The probability of miscarriage in women aged 20 to 30 at fewer than 20 weeks' gestation is 8.9%. When it comes to women over 40, this rises to 74.7%. Prior obstetrical history is a significant predictor of early pregnancy loss risk. After one loss, two consecutive miscarriages, or three or more consecutive miscarriages, the chance of miscarriage in a subsequent pregnancy is approximately 20%, 28%, and 43%, respectively.

The Gestational Diabetes Sub-Segment is Anticipated to Hold a Considerable Share of the Global Maternal Health Market

Among the complications, the gestational diabetes sub-segment is expected to hold a considerable share of the global maternal health market. The segmental growth is attributed to growing prevalence of gestation diabetes among population across the region. Gestational diabetes can be controlled with diet, exercise, and, in some cases, insulin therapy, depending on the severity. A chronic (long-lasting) medical condition called diabetes affects how the body converts food into energy. The goal of gestational diabetes treatment is to maintain blood glucose levels that are comparable to those of pregnant women without the condition. Special meal regimens, regular exercise schedules, daily blood glucose tests, and insulin injections are all part of the treatment. According to the Centers for Disease Control and Prevention, if a woman is not suffering from diabetes, she can develop gestational diabetes during pregnancy. Gestational diabetes affects somewhere between 2% and 10% of pregnancies each year in the US. Maintaining control of gestational diabetes ensures a safe pregnancy and a healthy delivery.

Regional Outlook

The global Maternal Health market is further segmented based on geography, including North America (the US and Canada), Europe (the UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and the Rest of Asia), and the Rest of the World (the Middle East and Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the increase in public health consciousness and a rise in demand for innovative medical technologies.

The North America Region is Expected to Grow at a Significant CAGR in the Global Maternal Health Market

Among all regions, North America is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to growing demand for family planning across the region. Women who possess the opportunity to utilize contraception and family planning services can space their pregnancies and lower their risk of difficulties. Accordingly, market players are coming up with new products to cater to the demand for maternal death rates. According to the Centers for Disease Control and Prevention, this report updates an earlier one that showed maternal death rates for the years 2018 to 2020. In the US, 1,205 women passed away owing to pregnancy-related causes in 2021, as opposed to 861 in 2020 and 754 in 2019. Compared to rates of 23.8 deaths per 100,000 live births in 2020 and 20.1 deaths per 100,000 live births in 2019, the maternal mortality rate for 2021 was 32.9. In 2021, non-Hispanic Black (thus, Black) women had a maternal mortality rate of 69.9 deaths per 100,000 live births, that was 2.6 times higher than the rate for non-Hispanic White (thus, White) women (26.6). Black women's rates were significantly higher than those of White and Hispanic women. Between 2020 and 2021, there were significant increases in individuals of Hispanic heritage and all other racial groups.

In 2018, the maternal mortality rate was 17.4 deaths per 100,000 live births, in 2019 it was 20.1 deaths per 100,000 live births, in 2020 it was 23.8 deaths per 100,000 live births, and in 2021 it was 32.9 deaths per 100,000 live births.

Market Players Outlook

The major companies serving the Maternal Health market include: Agile Therapeutics, Inc., Boston MedTech Advisors, Inc., Fuji Latex Co., Ltd., Johnson & Johnson Services, Inc., March of Dimes and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in December 2022, The New Jersey Health Care Quality Institute, in partnership with the Burke Foundation, launched the Maternal Infant Health (MIH) Hub, an innovative policy and learning partnership with a mission to advance midwifery practice in New Jersey while enhancing maternal/infant health and reducing racial/ethnic inequities.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global maternal health market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Agile Therapeutics, Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Boston MedTech Advisors, Inc.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. MCH Ventures, Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Maternal Health Market by Type
    • 4.1.1. Intrauterine
    • 4.1.2. Ectopic
    • 4.1.3. Tubal
    • 4.1.4. Others (Intra-Abdominal Pregnancy, Singlet Pregnancy, Multiple Pregnancy)
  • 4.2. Global Maternal Health Market by Complication
    • 4.2.1. Miscarriage
    • 4.2.2. Premature Labor & Birth
    • 4.2.3. Preeclampsia
    • 4.2.4. Gestational Diabetes
    • 4.2.5. Placenta Previa
    • 4.2.6. Others (Severe Bleeding, and Infections)
  • 4.3. Global Maternal Health Market by Care
    • 4.3.1. Prenatal Care
    • 4.3.2. Postnatal Care

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Apollo Hospitals Enterprise Ltd.
  • 6.2. Ann & Robert H. Lurie Children's Hospital of Chicago
  • 6.3. Cincinnati Children's Hospital Medical Center
  • 6.4. Fuji Latex Co., Ltd.
  • 6.5. Jiovio Healthcare
  • 6.6. Johnson & Johnson Services, Inc.
  • 6.7. March of Dimes
  • 6.8. McKinsey & Co.
  • 6.9. MedTech Boston
  • 6.10. Merck & Co., Inc.
  • 6.11. Okamoto Industries Co., Ltd.
  • 6.12. RAND Corp.
  • 6.13. Reckitt Benckiser Group
  • 6.14. Sanofi

LIST OF TABLES

  • 1. GLOBAL MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL INTRAUTERINE MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 3. GLOBAL ECTOPIC MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL TUBAL MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL OTHER TYPES OF MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY COMPLICATION, 2022-2030 ($ MILLION)
  • 7. GLOBAL MATERNAL HEALTH FOR MISCARRIAGE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL MATERNAL HEALTH FOR PREMATURE LABOR & BIRTH MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL MATERNAL HEALTH FOR PREECLAMPSIA MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL MATERNAL HEALTH FOR GESTATIONAL DIABETES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL MATERNAL HEALTH FOR PLACENTA PREVIA MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL MATERNAL HEALTH FOR OTHER COMPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY CARE, 2022-2030 ($ MILLION)
  • 14. GLOBAL PRENATAL MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. GLOBAL POSTNATAL MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 16. GLOBAL MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 19. NORTH AMERICAN MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY COMPLICATION, 2022-2030 ($ MILLION)
  • 20. NORTH AMERICAN MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY CARE, 2022-2030 ($ MILLION)
  • 21. EUROPEAN MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 22. EUROPEAN MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 23. EUROPEAN MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY COMPLICATION, 2022-2030 ($ MILLION)
  • 24. EUROPEAN MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY CARE, 2022-2030 ($ MILLION)
  • 25. ASIA- PACIFIC MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 26. ASIA- PACIFIC MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 27. ASIA- PACIFIC MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY COMPLICATION, 2022-2030 ($ MILLION)
  • 28. ASIA- PACIFIC MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY CARE, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 31. REST OF THE WORLD MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY COMPLICATION, 2022-2030 ($ MILLION)
  • 32. REST OF THE WORLD MATERNAL HEALTH MARKET RESEARCH AND ANALYSIS BY CARE, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL MATERNAL HEALTH MARKET SHARE BY TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL INTRAUTERINE MATERNAL HEALTH MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL ECTOPIC MATERNAL HEALTH MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL TUBAL MATERNAL HEALTH MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL OTHER TYPES OF MATERNAL HEALTH MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL MATERNAL HEALTH MARKET SHARE BY COMPLICATION, 2022 VS 2030 (%)
  • 7. GLOBAL MATERNAL HEALTH FOR MISCARRIAGE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL MATERNAL HEALTH FOR PREMATURE LABOR & BIRTH MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL MATERNAL HEALTH FOR PREECLAMPSIA MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL MATERNAL HEALTH FOR GESTATIONAL DIABETES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL MATERNAL HEALTH FOR PLACENTA PREVIA MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL MATERNAL HEALTH FOR OTHER COMPLICATIONS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL MATERNAL HEALTH MARKET SHARE ANALYSIS BY CARE, 2022-2030 ($ MILLION)
  • 14. GLOBAL PRENATAL MATERNAL HEALTH MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. GLOBAL POSTNATAL MATERNAL HEALTH MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 16. GLOBAL MATERNAL HEALTH MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 17. US MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. CANADA MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. UK MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. FRANCE MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. GERMANY MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. ITALY MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. SPAIN MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. REST OF EUROPE MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. INDIA MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. CHINA MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. JAPAN MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. SOUTH KOREA MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. REST OF ASIA-PACIFIC MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD MATERNAL HEALTH MARKET SIZE, 2022-2030 ($ MILLION)